Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rollover Access to Emtricitabine for FTC-203 Participants in South Africa
2015-000304-26Phase 2
- Sponsor
- Gilead Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of emtricitabine in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences.
02
Drugs
emtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2015-000304-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000304-26.